Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FCCSM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,490
Award facts
- Contract value 100% obligated
- $11,489.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,489.53 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 ml syringes on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Stelara is a biologic immunosuppressant medication used to treat conditions such as psoriasis, psoriatic arthritis, and Crohn's disease, reflecting the federal government's ongoing pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. The IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated consistent capability to meet federal requirements through competitive procurement across its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies.
Quick answers
Who was awarded contract SPE2DB25FCCSM?
SPE2DB25FCCSM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FCCSM worth?
The government has obligated $11,490 on SPE2DB25FCCSM.
Is contract SPE2DB25FCCSM an order under another contract?
Yes. SPE2DB25FCCSM is a delivery order under SPE2DB24D1007, an indefinite delivery contract.
Was contract SPE2DB25FCCSM competed?
The extent of competition for SPE2DB25FCCSM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award